Helen was Chief Business Officer at Blueprint Medicines, and Vice President, Head of Corporate Development at TCR² Therapeutics. Helen Ho joined Parabilis Medicines in 2026.
Helen Ho is currently
Create your alert
to follow the career of Helen Ho.
Helen Ho has a Bachelor of Science Biochemistry from University of California, Los Angeles and a Doctor in Cell Biology from Yale University.
They have also studied at University of California, Los Angeles :
Find more alumni from University of California, Los Angeles
They have also studied at Yale University :
Find more alumni from Yale University
Do you need to know more about Helen Ho? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.